Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMJGleeson Regulatory News (GLE)

Share Price Information for MJGleeson (GLE)

Share Price is delayed by 15 minutes
Get Live Data
245.00    0.00 (0.00%)
Bid:
245.00
Ask:
250.00
Spread: 5.00 (2.041%)
Market Cap: £142.92m
GLE Live PriceLast checked at - London Stock Exchange

Intraday MJGleeson Share Chart

Trading Statement

11 Jan 2013 07:00

RNS Number : 3136V
Gleeson(M J)Group PLC
11 January 2013
 



 

11 January 2013

 

MJ GLEESON GROUP PLC

TRADING UPDATE

 

MJ Gleeson Group plc (GLE.L) is today issuing the following Trading Update ahead of its Half Year Results to 31 December 2012, which will be released on Thursday 28 February 2013.

 

Gleeson Homes

 

Gleeson Homes sold 164 private development homes during the period, an increase of 53% compared with the previous year's total of 107. With the inclusion of units sold to Housing Associations, the total for the period is 165 homes, compared to 130 in the comparable period.

 

Total sales, comprising reserved, contracted and completed homes, rose by 65% to £33.2m.

 

The Government's FirstBuy scheme, which provides support to first time buyers by way of a 20% equity loan, has been very popular with our customers. We have recently secured an additional allocation of £2.0m of FirstBuy funding, which will provide assistance to about 170 first time buyers.

 

During the period Gleeson Homes has continued to increase its landbank of plots with the addition of 331 plots. The landbank of plots at 31 December comprises 2,099 plots owned with a further 1,530 plots conditionally purchased, which, if acquired, will increase the landbank to in excess of 3,600 plots.

 

Gleeson Strategic Land

 

Demand for green field residential land in the South of England from the major housebuilders remains strong. During the period Gleeson Strategic Land sold three sites, with a combined acreage of 13 acres.

 

Contracts were exchanged for the sale of the first phase of a 77 acre site in Thanet, in which the Group has 50% interest. The works to install the infrastructure for the whole of the site have now commenced.

 

During the period, planning permission was achieved on a 133 unit site at Grove, Oxfordshire and an 18 unit site at Hunston, West Sussex. Both sites are being marketed for sale in 2013.

 

The strategic land portfolio continues to be replenished. During the period, agreements were entered into regarding six new sites, comprising 126 acres.

 

 

 

The Group's cash balances at 31 December 2012 stood at £10.4m.

Jolyon Harrison, Chief Executive, commented:

 

"The performance in the first half of the financial year of both Gleeson Homes and Gleeson Strategic Land is encouraging, with profits expected to be significantly ahead of last year. The housing market remains challenging. The Group, however, remains on track to deliver a strong and sustained improvement in its performance."

 

 

 

Enquiries:

 

M J Gleeson Group plc

Jolyon Harrison Chief Executive Officer 0114 261 2900

Alan Martin Chief Financial Officer 01252 360 300

 

 

Notes to Editors

 

MJ Gleeson Group plc operates in the house building sector through the following business units; Gleeson Homes, which focuses on estate regeneration and housing development on brownfield land in the North of England; and Gleeson Strategic Land, which purchases options over land in the South of England with the objective of enhancing the value of the site concerned by securing residential planning permission.

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTBRGDBSDBBGXG
Date   Source Headline
30th Nov 20237:00 amRNSTotal Voting Rights
27th Nov 20234:29 pmRNSDirector/PDMR Shareholding
16th Nov 20231:33 pmRNSResult of AGM
16th Nov 20237:00 amRNSAGM Trading Update
8th Nov 20233:29 pmRNSDirector/PDMR Shareholding
31st Oct 20237:00 amRNSTotal Voting Rights
24th Oct 20234:17 pmRNSDirector/PDMR Shareholding
23rd Oct 20231:56 pmRNSExercise of Options & Director/ PDMR Dealing
17th Oct 20237:00 amRNSNotice of AGM
6th Oct 20232:37 pmRNSDirector/PDMR Shareholding
29th Sep 20237:00 amRNSTotal Voting Rights
27th Sep 20234:17 pmRNSExercise of Options & PDMR Dealing
26th Sep 20234:38 pmRNSDirector/PDMR Shareholding
15th Sep 20233:54 pmRNSDirector/PDMR Shareholding
15th Sep 202310:35 amRNSDirector/PDMR Shareholding
14th Sep 20234:41 pmRNSDirector/PDMR Shareholding
14th Sep 20237:00 amRNSAudited results for the year ended 30 June 2023
7th Sep 202312:20 pmRNSDirector/PDMR Shareholding
31st Aug 20237:00 amRNSTotal Voting Rights
8th Aug 20234:55 pmRNSDirector/PDMR Shareholding
31st Jul 20237:00 amRNSTotal Voting Rights
7th Jul 20233:48 pmRNSDirector/PDMR Shareholding
7th Jul 20237:00 amRNSTrading Update and Capital Markets Day
30th Jun 20237:00 amRNSSale of portfolio of homes to Carlyle
30th Jun 20237:00 amRNSTotal Voting Rights
8th Jun 20232:23 pmRNSDirector/PDMR Shareholding
31st May 20237:00 amRNSTotal Voting Rights
15th May 20233:30 pmRNSHolding(s) in Company
10th May 20231:56 pmRNSDirector/PDMR Shareholding
28th Apr 20237:00 amRNSTotal Voting Rights
14th Apr 202310:01 amRNSDirector/PDMR Shareholding
6th Apr 202311:13 amRNSDirector/PDMR Shareholding
5th Apr 20234:37 pmRNSDirector/PDMR Shareholding
31st Mar 20237:00 amRNSTotal Voting Rights
29th Mar 20237:00 amRNSDirector/PDMR Shareholding
24th Mar 20237:00 amRNSRe Directorate
21st Mar 20237:00 amRNSNotice of Capital Markets Day and Trading Update
13th Mar 20233:58 pmRNSSigning of the Self-Remediation Terms
8th Mar 20235:13 pmRNSDirector/PDMR Shareholding
28th Feb 20237:00 amRNSTotal Voting Rights
27th Feb 202312:05 pmRNSPerformance Share Plan award to Directors & PDMRs
16th Feb 20237:00 amRNSResults for the half-year ended 31 December 2022
8th Feb 20235:18 pmRNSCommittee appointments
8th Feb 20231:45 pmRNSDirector/PDMR Shareholding
31st Jan 20237:00 amRNSTotal Voting Rights
13th Jan 20237:00 amRNSTrading Update & Notice of Results
6th Jan 20234:42 pmRNSDirector/PDMR Shareholding
3rd Jan 20237:00 amRNSRe Directorate
30th Dec 20227:00 amRNSTotal Voting Rights
15th Dec 202211:06 amRNSDirectorate External Appointments

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.